Los Angeles Capital Management’s Atea Pharmaceuticals AVIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$224K Buy
2025
Q2
$123K Buy
2023
Q1
Sell
2022
Q4
$842K Sell
2022
Q3
$1.01M Sell
2022
Q2
$1.43M Sell
2022
Q1
$1.67M Buy